BURLINGTON, Ontario, June 02, 2022--(BUSINESS WIRE)--Element Nutritional Sciences Inc. (CSE:ELMT; OTC:ELNSF; FRANKFURT:93X) (the "Company" or "Element"), is pleased to announced that it has signed Dr. James LaValle to an exclusive two-year agreement to represent the Company’s patented Rejuvenate™ and Promino™ products. Dr. LaValle will appear in television and digital campaigns to highlight the company’s unique IP-driven products clinically proven to prevent muscle loss, improve tone and build muscle.

Dr. LaValle is a clinical pharmacist and board-certified clinical nutritionist with over 35 years’ experience in practising wellness, prevention and disease state management. Dr. LaValle is the author of 19 books and over 200 articles, he has made over 1,000 media appearances, he has consulted for organization such as Proctor & Gamble and Bayer, and worked with athletes from teams such as the Toronto Maple Leafs, New England Patriots and Houston Astros. He was appointed to the Inaugural Dietary Supplement Information Bureau Board and was previously a Faculty of the Year award winner from the American Academy of Anti-Aging Medicine. More information on Dr. LaValle can be found here.

Stuart Lowther, Chief Executive Officer of Element said, "We chose to partner with Dr. LaValle because of his excellent track record in the fields of nutrition and metabolism. Dr. LaValle understands the global opportunity in improving muscle health and is well acquainted with the research that supports the efficacy of the patented amino formulation that underpins our Rejuvenate™ and Promino™ products. In the next two years, we expect that Dr. LaValle with help generate awareness for Rejuvenate™ and Promino™ products and help consumers understand how Element can help them live their lives to the fullest."

Element is an innovative and research driven Canadian nutraceutical company specializing in the development of patented and science-based products for the global consumer packaged goods market, with a portfolio focused specifically on men and women over the age of 40. Element’s lead product, Rejuvenate™, is a proprietary formulation that is clinically proven to assist in the rebuilding, restoration and rejuvenation of natural loss of muscle mass due to aging or other medical conditions. Element also offers JAKTRX™, an elite brand of performance supplements. Element was founded in 2015 and is located in Burlington, Ontario.

To learn more about Element, visit elmtinc.com.

More information about Rejuvenate™ can be found at: www.rejuvenatemuscle.com

More information about JAKTRX™ and Promino™ can be found at: www.jaktrx.com

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward looking statements relate, among other things, to: Dr. LaValle’s ability to help generate awareness for Rejuvenate™ and Promino™ products.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: fluctuations in general macroeconomic conditions; expectations regarding the size of the United States and Canadian health, nutraceutical and wellness markets and changing consumer habits; the viability of the Company’s products; availability of distribution channels for the Company’s product offerings; the ability of the Company to successfully achieve its business objectives; plans for expansion; successful development of the Company’s proposed products; the presence of laws and regulations that may impose restrictions or recalls on the sale of the Company’s products in the United States and Canada; customer and distributor relations; fluctuations in securities markets; and the inability of the Company to obtain adequate insurance to cover risks and hazards. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220601006198/en/

Stuart Lowther Chairman, CEO and President ir@elementnutrition.com 416-467-5229 Marc Charbin Investor Relations ir@elementnutrition.com 416-467-5229

STORY: Shares of Microsoft fell on Thursday, after the tech giant cut its profit and revenue outlooks for the current quarter, making it the latest American company to warn of a hit from a stronger U.S. dollar. The Federal Reserve's fight against inflation and heightened geopolitical tensions have driven a 14% gain in the dollar against a basket of currencies over the last year, forcing other companies such as Coca-Cola and Procter & Gamble to temper expectations for the rest of the year. A stronger dollar typically eats into the profits of companies with operations all over the world that convert foreign currency into American money and has added to corporate worries over soaring inflation. Microsoft gets about half its revenue from outside the United States, so the company lowered its revenue forecast for Windows products, as well as cloud and personal computing - which one analyst called a "prudent" move. Microsoft said it now expects to report as much as $52.7 billion in revenue for the quarter, after previously forecasting as much as $53.2 billion.

These big names are down — but certainly not out.

The Dow Jones fell on strong jobs data. Tesla stock plunged on an Elon Musk move. Apple stock crumbled. Amazon fell after an executive quit.

In the world of stock legends, Ken Fisher stands out. The legendary investor founded his private financial advisory firm, Fisher Investments, in 1979, with just $250 in seed money. Today, Fisher’s company manages over $195 billion in total assets, and his personal net work exceeds $5 billion. Fisher has cast his eye on current market conditions. In recent published note, Fisher points out the obvious headwinds in the current environment: “Fear of the impact of the tragic, grinding war in Ukraine

Semiconductor specialist Nvidia (NASDAQ: NVDA) was down as much as 5.5%, iPhone maker Apple (NASDAQ: AAPL) was off by as much as 4.5%, and e-commerce kingpin Amazon (NASDAQ: AMZN) slipped as much as 3.5%. New warnings about the possibility of a recession sent a wide swath of stocks lower today, but there was also company-specific news for each of the technology stalwarts. Tesla CEO Elon Musk joined the chorus of business leaders sounding the alarm about the economy and the possibility of a recession.

It was a tough day for high-growth stocks, as a hot jobs number stoked inflation fears even as Elon Musk warned about the global economy.

Yahoo Finance auto reporter Pras Subramanian breaks down data from a new report indicating depressed U.S. auto sales amid rising inflation and interest rates.

Don’t bail on stocks. Just choose them wisely.

Amazon stock is working on its sixth straight daily rally ahead of its 20-for-1 stock split. Here's what the charts say now.

Piper Sandler is scared of a computer memory glut, but Micron's stock price is cheap enough to already factor that in.

(Bloomberg) -- Novavax Inc. slumped 20% on Friday after US regulators raised concerns over the biotech’s much-anticipated Covid-19 vaccine. Most Read from BloombergOne-Third of Americans Making $250,000 Live Paycheck-to-Paycheck, Survey FindsTesla Pauses Hiring as Musk Aims for 10% Staff Cut, Reuters Says‘Most Clever Oligarch’ Severed His $37 Billion Fortune From Russian RootsElon Musk’s Ultimatum to Tesla Execs: Return to the Office or Get OutStocks Resume Weekly Losses as Jobs Fuel Rate Bets:

One of the proposed shareholder measures, which was expected to be rubber-stamped by investors, has hit some surprising resistance.

The Dow Jones Industrial Average dropped after the jobs report. Tesla skidded after Musk said he had a "super bad feeling" about the economy.

(Bloomberg) -- China has sentenced a former Communist Party city chief and securities regulator to death with a two-year reprieve for bribery and insider trading, state broadcaster CCTV reported.Most Read from BloombergOne-Third of Americans Making $250,000 Live Paycheck-to-Paycheck, Survey FindsTesla Pauses Hiring as Musk Aims for 10% Staff Cut, Reuters SaysElon Musk’s Ultimatum to Tesla Execs: Return to the Office or Get OutApple Plans to Make the iPad More Like a Laptop and Less Like a PhoneU

Brave investors are trying to buy S&P 500 stocks on the dip. But they're not even crazy enough to touch some.

In this article, we will take a look at the 11 stocks in focus after releasing their earnings reports. You can skip our detailed analysis of these companies and go directly to the 5 Stocks in Focus After Releasing Their Earnings Reports. Recently, popular tech stocks, including Salesforce, Inc. (NYSE:CRM), NetApp, Inc. (NASDAQ:NTAP) and Pure […]

See who joins Nvidia and GOOGL on this screen of Warren Buffett stocks based on the investing strategy of Berkshire Hathaway's CEO.

We feel now is a pretty good time to analyse NIO Inc.'s ( NYSE:NIO ) business as it appears the company may be on the...

It helped lead a rally in chip stocks, as Nvidia also did well, gaining 6.9%. AMD stock not only rotated over the prior month's high, it also held a key support level. What does that have to do with this week's breakout?

What happened American Airlines Group (NASDAQ: AAL) was the opposite of a high-flying stock on Friday. At the close of trading, the big carrier's share price was down by 7.1%. Investors were clearly concerned about updated guidance the company issued earlier in the day.